Mentioned On
Episode Mentions
Huberman Lab · Mar 9, 2026
Avoiding, Treating & Curing Cancer With the Immune System | Dr. Alex Marson
“Pharmaceutical company leading development of bispecific T cell engager antibody therapies”
CAR-T cell therapyCRISPR gene editingCancer immunotherapy
View Analysis
Victor Davis Hanson: In His Own Words · Feb 10, 2026
Big Tech Wanted ‘Clean Energy.’ Ohio Gave Natural Gas | Rep. Troy Balderon
“Pharmaceutical company investing $300 million in Ohio's 12th congressional district with substantial power requirements”
Marcellus and Utica Shale natural gas extraction and reservesEnergy infrastructure permitting and interconnection queue delaysBaseload power generation requirements for AI data centers
View Analysis
Mad Money w/ Jim Cramer · Feb 5, 2026
Mad Money w/ Jim Cramer 2/4/26
“Established pharma company with solid earnings and buybacks; competing in GLP-1 space”
GLP-1 Drug Competition and Pricing StrategyEnterprise Software Industry Disruption by AIMarket Rotation from Growth to Value Stocks
View Analysis
BG2Pod with Brad Gerstner and Bill Gurley · Sep 11, 2025
Inside OpenAI Enterprise: Forward Deployed Engineering, GPT-5, and More | BG2 Guest Interview
OpenAI Enterprise PlatformForward Deployed EngineeringGPT-5 Development
View Analysis
Chief Change Officer · Jun 13, 2025
#411 Mark Bayer: From Ivory Tower to Power Play — Helping PhDs Get Heard (and Hired) — Part One
“Mentioned as a biotech company where PhD holders seek employment after leaving academic research.”
PhD Career Transitions to IndustryScientific Communication and PersuasionAcademic-to-Business Skills Gap
View Analysis